Phase IIA Study in Patients With Schizophrenia

NCT00686998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: AZD2624
DRUG: Olanzapine
DRUG: Placebo

Sponsor

AstraZeneca